{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:26:59Z","timestamp":1787023619877,"version":"build-2736575974"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,7,26]]},"DOI":"10.18632\/oncotarget.10268","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T10:01:43Z","timestamp":1466762503000},"page":"48391-48400","source":"Crossref","is-referenced-by-count":23,"title":["Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Tianling","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Biskup","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Mette","family":"Rahbek Gjerdrum","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zealand University Hospital, K\u00f8ge, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Niazi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"\u00d8dum","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark"},{"name":"Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gniadecki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark"},{"name":"Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,6,24]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ajh.22139","article-title":"Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management","volume":"86","author":"Wilcox","year":"2011","journal-title":"American journal of hematology"},{"key":"2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Kempf","year":"2005","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2011.08852.x","article-title":"Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)","volume":"155","author":"Porcu","year":"2011","journal-title":"British journal of haematology"},{"key":"4","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2008-05-154609","article-title":"Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation","volume":"112","author":"McCormack","year":"2008","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","article-title":"A genomic and functional inventory of deubiquitinating enzymes","volume":"123","author":"Bernards","year":"2005","journal-title":"Cell"},{"key":"6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.biochi.2007.09.013","article-title":"Targeting ubiquitin specific proteases for drug discovery","volume":"90","author":"Colland","year":"2008","journal-title":"Biochimie"},{"key":"7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrc1994","article-title":"Ubiquitin and ubiquitin-like proteins in cancer pathogenesis","volume":"6","author":"Dikic","year":"2006","journal-title":"Nature reviews Cancer"},{"key":"8","first-page":"255","article-title":"The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases","volume":"3","author":"Maldonado","year":"2006","journal-title":"Cellular & molecular immunology"},{"key":"9","first-page":"5","article-title":"The ubiquitin-proteasome pathway in viral infections","volume":"84","author":"Luo","year":"2006","journal-title":"Canadian journal of physiology and pharmacology"},{"key":"10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/10428199409056292","article-title":"Radiotherapy in early stage Hodgkin's disease","volume":"13","author":"Miniaci","year":"1994","journal-title":"Leukemia & lymphoma"},{"key":"11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives","volume":"11","author":"Dou","year":"2011","journal-title":"Current cancer drug targets"},{"key":"12","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2011.443","article-title":"Deubiquitinases in cancer: new functions and therapeutic options","volume":"31","author":"Lopez-Otin","year":"2012","journal-title":"Oncogene"},{"key":"13","doi-asserted-by":"crossref","first-page":"e812","DOI":"10.1038\/cddis.2013.289","article-title":"USP2a alters chemotherapeutic response by modulating redox","volume":"4","author":"Blandino","year":"2013","journal-title":"Cell death & disease"},{"key":"14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4161\/cc.11.6.19550","article-title":"The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer","volume":"11","author":"Freeman","year":"2012","journal-title":"Cell cycle"},{"key":"15","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1158\/0008-5472.CAN-06-1374","article-title":"The isopeptidase USP2a protects human prostate cancer from apoptosis","volume":"66","author":"Loda","year":"2006","journal-title":"Cancer research"},{"key":"16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1535-6108(04)00055-8","article-title":"The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer","volume":"5","author":"Loda","year":"2004","journal-title":"Cancer cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.emboj.7601567","article-title":"The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2","volume":"26","author":"Saville","year":"2007","journal-title":"The EMBO journal"},{"key":"18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/onc.2009.330","article-title":"MdmX is a substrate for the deubiquitinating enzyme USP2a","volume":"29","author":"Saville","year":"2010","journal-title":"Oncogene"},{"key":"19","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1038\/onc.2012.188","article-title":"The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation","volume":"32","author":"Loda","year":"2013","journal-title":"Oncogene"},{"key":"20","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/cdd.2011.3","article-title":"Control of AIF-mediated cell death by antagonistic functions of CHIP ubiquitin E3 ligase and USP2 deubiquitinating enzyme","volume":"18","author":"Chung","year":"2011","journal-title":"Cell death and differentiation"},{"key":"21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.molcel.2009.10.018","article-title":"Suppression of cancer cell growth by promoting cyclin D1 degradation","volume":"36","author":"Gu","year":"2009","journal-title":"Molecular cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"38960","DOI":"10.1074\/jbc.M111.231498","article-title":"Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A","volume":"286","author":"Liu","year":"2011","journal-title":"The Journal of biological chemistry"},{"key":"23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3727\/000000003108749053","article-title":"Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69","volume":"11","author":"Baker","year":"2003","journal-title":"Gene expression"},{"key":"24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.0022-202X.2005.23864.x","article-title":"Increased sensitivity to interferon-alpha in psoriatic T cells","volume":"125","author":"Odum","year":"2005","journal-title":"The Journal of investigative dermatology"},{"key":"25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archderm.141.3.305","article-title":"Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy","volume":"141","author":"Guitart","year":"2005","journal-title":"Archives of dermatology"},{"key":"26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0923-1811(00)00159-6","article-title":"Early mycosis fungoides: molecular analysis for its diagnosis and the absence of p53 gene mutations in cases with progression","volume":"26","author":"Parwaresch","year":"2001","journal-title":"Journal of dermatological science"},{"key":"27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1523-1747.2002.01794.x","article-title":"Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin","volume":"118","author":"Kadin","year":"2002","journal-title":"The Journal of investigative dermatology"},{"key":"28","first-page":"46","article-title":"The role of p53 and anaplastic lymphoma kinase genes in the progression of cutaneous CD30(+) lymphoproliferative diseases","volume":"121","author":"Parwaresch","year":"2005","journal-title":"The Indian journal of medical research"},{"key":"29","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/jid.2012.10","article-title":"Mdm2 inhibitor nutlin-3a induces apoptosis and senescence in cutaneous T-cell lymphoma: role of p53","volume":"132","author":"Gniadecki","year":"2012","journal-title":"The Journal of investigative dermatology"},{"key":"30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"activation of the p53 pathway by small-molecule antagonists of Mdm2","volume":"303","author":"Liu","year":"2004","journal-title":"Science"},{"key":"31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/CMAR.S4555","article-title":"Bortezomib in the management of multiple myeloma","volume":"1","author":"Richardson","year":"2009","journal-title":"Cancer management and research"},{"key":"32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jocn.2012.03.050","article-title":"Up-regulation of USP2a and FASN in gliomas correlates strongly with glioma grade","volume":"20","author":"Lu","year":"2013","journal-title":"Journal of clinical neuroscience"},{"key":"33","first-page":"504","article-title":"[Differential expression of USP2, USP14 and UBE4A between ovarian serous cystadenocarcinoma and adjacent normal tissues]","volume":"23","author":"Yang","year":"2007","journal-title":"Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology"},{"key":"34","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.154.5.1403","article-title":"Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor","volume":"154","author":"Gallo","year":"1981","journal-title":"The Journal of experimental medicine"},{"key":"35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00431220","article-title":"A continuous T-cell line from a patient with Sezary syndrome","volume":"279","author":"Sterry","year":"1987","journal-title":"Archives of dermatological research"},{"key":"36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood.V55.3.409.409","article-title":"Mitogen requirements for thepropagation of cutaneous T-cell lymphomas","volume":"55","author":"Guccion","year":"1980","journal-title":"Blood"},{"key":"37","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2009-12-260216","article-title":"Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma","volume":"116","author":"Gniadecki","year":"2010","journal-title":"Blood"},{"key":"38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2133.2007.08427.x","article-title":"Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders","volume":"158","author":"Gniadecki","year":"2008","journal-title":"The British journal of dermatology"},{"key":"39","doi-asserted-by":"crossref","first-page":"e29541","DOI":"10.1371\/journal.pone.0029541","article-title":"miR-122 regulates p53\/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma","volume":"7","author":"Gniadecki","year":"2012","journal-title":"PloS one"},{"key":"40","doi-asserted-by":"crossref","first-page":"e59390","DOI":"10.1371\/journal.pone.0059390","article-title":"cMyc\/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas","volume":"8","author":"Gniadecki","year":"2013","journal-title":"PloS one"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T17:39:31Z","timestamp":1600796371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,24]]},"references-count":40,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2016,7,26]]}},"alternative-id":["10268","27351221"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10268","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,24]]}}}